Clinical Trial Update: A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique [Phase 3]

View source ↗

Summary

Phase 3 trial comparing day 1 versus day 6 initiation of ovarian stimulation using GONAL-f and Luveris in women undergoing assisted reproductive techniques; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicle-stimulating Hormone Deficiency
• Infertility

Drugs mentioned

• Gonal-F (follitropin alfa)
• Luveris (lutropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility, Fertility | Phase 3 | Status: TERMINATED | Results posted: 2015-11-09